Search research articles
Contact Us
Filters
Showing results (51-60 of 133) with videos related to
Page
of 14
Sort By:
Structure (London, England : 1993)
|
November 18, 2000
Structural basis for the resilience of efavirenz (DMP-266) to drug resistance mutations in HIV-1 reverse transcriptase
J Ren, J Milton, K L Weaver, et al.
Annals of the New York Academy of Sciences
|
July 21, 1995
The crystal structure of murine leukemia inhibitory factor
R C Robinson, L M Grey, D Staunton, et al.
The Journal of Biological Chemistry
|
May 9, 2000
Binding of the second generation non-nucleoside inhibitor S-1153 to HIV-1 reverse transcriptase involves extensive main chain hydrogen bonding
J Ren, C Nichols, L E Bird, et al.
Nature
|
November 6, 1986
Alpha-lactalbumin possesses a novel calcium binding loop
D I Stuart, K R Acharya, N P Walker, et al.
Acta Crystallographica. Section D, Biological Crystallography
|
February 22, 2003
Crystallization of the membrane-containing bacteriophage PRD1 in quartz capillaries by vapour diffusion
J J B Cockburn, J K H Bamford, J M Grimes, et al.
Progress in Clinical and Biological Research
|
January 1, 1984
The role of pyridoxal phosphate in glycogen phosphorylase b; structure, environment and relationship to catalytic mechanism
M S Sansom, Y S Babu, J Hajdu, et al.
Journal of Medicinal Chemistry
|
December 2, 1999
Design of MKC-442 (emivirine) analogues with improved activity against drug-resistant HIV mutants
A L Hopkins, J Ren, H Tanaka, et al.
Biochemical Society Transactions
|
June 1, 1981
The structure and function of pyruvate kinase
H Muirhead, J P Grant, M A Lawton, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences
|
June 26, 1981
Phosphorylase: control and activity
J A Jenkins, L N Johnson, D I Stuart, et al.
Journal of Molecular Biology
|
September 29, 2001
Structural mechanisms of drug resistance for mutations at codons 181 and 188 in HIV-1 reverse transcriptase and the improved resilience of second generation non-nucleoside inhibitors
J Ren, C Nichols, L Bird, et al.
Page
of 14
Search research articles
Search
Showing results (51-60 of 133) with videos related to
Sort By:
Page
of 14
Structure (London, England : 1993)
|
November 18, 2000
Structural basis for the resilience of efavirenz (DMP-266) to drug resistance mutations in HIV-1 reverse transcriptase
J Ren, J Milton, K L Weaver, et al.
Annals of the New York Academy of Sciences
|
July 21, 1995
The crystal structure of murine leukemia inhibitory factor
R C Robinson, L M Grey, D Staunton, et al.
The Journal of Biological Chemistry
|
May 9, 2000
Binding of the second generation non-nucleoside inhibitor S-1153 to HIV-1 reverse transcriptase involves extensive main chain hydrogen bonding
J Ren, C Nichols, L E Bird, et al.
Nature
|
November 6, 1986
Alpha-lactalbumin possesses a novel calcium binding loop
D I Stuart, K R Acharya, N P Walker, et al.
Acta Crystallographica. Section D, Biological Crystallography
|
February 22, 2003
Crystallization of the membrane-containing bacteriophage PRD1 in quartz capillaries by vapour diffusion
J J B Cockburn, J K H Bamford, J M Grimes, et al.
Progress in Clinical and Biological Research
|
January 1, 1984
The role of pyridoxal phosphate in glycogen phosphorylase b; structure, environment and relationship to catalytic mechanism
M S Sansom, Y S Babu, J Hajdu, et al.
Journal of Medicinal Chemistry
|
December 2, 1999
Design of MKC-442 (emivirine) analogues with improved activity against drug-resistant HIV mutants
A L Hopkins, J Ren, H Tanaka, et al.
Biochemical Society Transactions
|
June 1, 1981
The structure and function of pyruvate kinase
H Muirhead, J P Grant, M A Lawton, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences
|
June 26, 1981
Phosphorylase: control and activity
J A Jenkins, L N Johnson, D I Stuart, et al.
Journal of Molecular Biology
|
September 29, 2001
Structural mechanisms of drug resistance for mutations at codons 181 and 188 in HIV-1 reverse transcriptase and the improved resilience of second generation non-nucleoside inhibitors
J Ren, C Nichols, L Bird, et al.
Page
of 14